Your Source for Venture Capital and Private Equity Financings

Ansa Nets $71.5M Series C

2026-11-18
EMERYVILLE, CA, Ansa Biotechnologies, a trusted partner for DNA synthesis, announced the closing of a $71.5 million oversubscribed Series C financing, led by Blue Water Life Science Advisors.
Ansa Biotechnologies, a trusted partner for DNA synthesis, announced the closing of a $71.5 million oversubscribed Series C financing, bringing its total funding to $211 million. The investment comes amid accelerating demand for Ansa's ability to deliver long, complex synthetic DNA with a guaranteed ship date, which enables researchers to pursue more ambitious experiments using biological designs that conventional synthesis methods struggle to manufacture.

Led by Blue Water Life Science Advisors, the round included new investors Illumina Ventures, BEVC, Lightscape Partners, and Agent Capital, along with existing investors Cerberus Ventures, Fall Line Capital, Dauntless Ventures, and Altitude Life Science Ventures.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors